Ternary Health
Adipose Tissue Disorders · FML

Familial Multiple Lipomatosis

When lipomas are described as 'just cosmetic' but they keep multiplying, hurt, and run in your family — it deserves a real evaluation, not a shrug.

About FML

What we mean when we say FML.

Familial Multiple Lipomatosis (FML) is an inherited disorder characterized by the development of multiple discrete, encapsulated lipomas, most commonly across the trunk and extremities. Inheritance is typically autosomal dominant with variable expression.

While individual lipomas are benign, the cumulative burden — cosmetic, functional, and sometimes painful — can significantly impact quality of life. FML often coexists with other adipose disorders including lipedema, Madelung's disease, and Dercum's disease, suggesting shared pathways that remain incompletely characterized.

Management is largely surgical for symptomatic lesions, but the choice between excision, liposuction-based techniques, and observation requires clinical judgment that few generalists are equipped to provide.

Prevalence

True prevalence unknown; estimated at less than 1 in 50,000. Strong family clustering with autosomal dominant inheritance pattern in many kindreds.

The path to diagnosis

Why FML gets missed.

Autosomal dominant
Inheritance pattern in most families
FML clinical genetics literature
Lipedema, Madelung's, Dercum's
Frequently coexists with
Adipose-disorder clinical literature

Familial Multiple Lipomatosis is usually diagnosed — the lipomas are visible and palpable — but rarely contextualized. The condition is treated as a cosmetic concern one lipoma at a time, rather than as a systemic disorder of adipose tissue that may sit within a broader cluster.

  1. 01
    Each lipoma is evaluated in isolation. Patients are referred to general surgery or dermatology for excision of individual masses without anyone mapping the cumulative burden or pursuing the family pedigree.
  2. 02
    Family history is rarely pursued in any structured way. The autosomal dominant inheritance pattern in many FML kindreds means parents, siblings, and children are often affected and undiagnosed.
  3. 03
    Coexisting adipose disorders — lipedema, Madelung's, Dercum's — are missed because the FML lipomas are taken as the explanation for all subcutaneous changes. The painful, symmetric, or distribution-specific findings that would suggest another diagnosis get attributed to FML.
  4. 04
    Surgical decision support is weak. The choice between traditional excision, liposuction-based techniques, and observation depends on lipoma size, location, growth rate, and patient priorities — but is most often driven by which technique the available surgeon performs.
How we approach it

The Ternary Health approach to Familial Multiple Lipomatosis.

01

Map the full lipoma burden — distribution, size, growth pattern, symptomatic versus asymptomatic — rather than evaluating each mass individually. The cumulative picture changes the surgical strategy.

02

Construct the family pedigree systematically: parents, siblings, children, and where available, second-degree relatives. The autosomal dominant pattern matters for affected family members and for genetic counseling considerations.

03

Evaluate for coexisting adipose disorders — lipedema, Madelung's, Dercum's — that frequently cluster with FML and require different management. The differential is the value here.

04

Audit surgical options against the specific case: excision for large or symptomatic lesions, liposuction-based techniques for distribution-pattern debulking, and observation criteria for lesions that don't warrant intervention.

Signals we look for

The Ternary Signal Library for FML.

Our Signal Library for FML codifies the specific patterns that matter — distribution, family pedigree, differential diagnosis, and surgical candidacy. Your case is mapped against these signals; each present signal is identified and prioritized for your presentation.

Lipoma Distribution & Anatomy
  • Total lipoma count and anatomic distribution map
  • Size distribution and growth-rate documentation
  • Symptomatic versus asymptomatic lesion characterization
  • Imaging — ultrasound and MRI where indicated for depth and infiltration
  • Location-specific functional impact assessment
Family Pedigree & Inheritance
  • Three-generation family pedigree construction
  • Affected relatives — confirmed and suspected
  • Inheritance pattern — autosomal dominant in most kindreds
  • Genetic testing considerations and current limitations
  • Counseling implications for affected family members
Adipose-Disorder Differential
  • Lipedema screening — symmetric, painful, lower-body distribution
  • Madelung's pattern — neck, shoulders, upper trunk symmetry
  • Dercum's pattern — painful lipomas, fatigue, cognitive symptoms
  • Metabolic markers — triglycerides, insulin, hepatic panel
  • Connective tissue findings — hypermobility, skin findings
Surgical Candidacy & History
  • Prior surgical history — technique, outcomes, recurrence
  • Excision versus liposuction comparative evidence per lesion
  • Surgeon experience and adipose-disorder familiarity
  • Recurrence risk by technique and location
  • Cosmetic versus functional indication weighting
The nine-stage workflow, applied

How a FML case moves through our workflow.

Our nine-stage workflow is the same for every engagement. What changes per condition is the content at each stage — the records we pull, the signals we apply, the specialists we map, the pathways we evaluate. Below, how your case specifically would move through each stage.

Stage 01 · 0–2
Qualification
Fit screen confirms diagnosed or strongly suspected FML, access to records and imaging, and current symptom and treatment status. Family history availability matters for case prioritization.
Stage 02 · 3–6
Intake & data aggregation
Records pull emphasizes prior surgical pathology, imaging, and any metabolic workup. A structured lipoma inventory is built — location, size, growth, symptom status. Family history collected systematically.
Stage 03 · 6–9
Case structuring
Case schema populated. Pedigree constructed and analyzed. Coexisting adipose-disorder screen performed in parallel — lipedema, Madelung's, Dercum's distributions evaluated.
Stage 04 · 9–12
Signal analysis
The Ternary Signal Library for FML is applied. Typical case activates 8–14 signals across distribution, pedigree, differential, and surgical candidacy domains. Each signal evaluated for your specific presentation.
Stage 05 · 12–16
Evidence retrieval
Literature scan emphasizes the FML clinical genetics series, comparative surgical outcomes for excision versus liposuction-based techniques, and the cross-disorder adipose literature linking FML to lipedema, Madelung's, and Dercum's. Condition-specific Evidence Matrix refreshed.
Stage 06 · 16–20
Pathway mapping
Pathway map built across general surgery, plastic and reconstructive surgery experienced with adipose disorders, medical genetics where pedigree work warrants it, and metabolic workup. Specialists mapped from our Specialist Graph.
Stage 07 · 20–24
Synthesis & plan construction
Every option weighed against the three questions (Evidence × Personalization × Action), then prioritized and sequenced. Dependencies encoded as a directed graph — differential resolution informs management approach, surgical sequencing informs cosmetic and functional priorities.
Stage 08 · 24–28
Delivery & calibration
Findings call with attention to surgical decision sequencing, family counseling considerations, and adipose-comorbidity workup priorities. Your priorities and constraints update the plan before finalization.
Stage 09 · 28–58
Execution support
30 days of asynchronous follow-up through the typical FML consultation sequence — plastic or general surgery, genetics where indicated, and metabolic workup. Outcomes captured into the Ledger.
Deliverables

What you receive.

  • A written case synthesis covering lipoma distribution, family pedigree, and differential diagnosis
  • Integration of imaging, pathology, and adipose-disorder workup into a single view
  • Three-generation family pedigree with affected-relative mapping
  • A surgical decision framework comparing excision and liposuction-based techniques per lesion
  • Specialist identification for adipose-disorder-experienced surgeons and any indicated genetics or metabolic workup
  • A written action plan and follow-up support as you implement it
What a Ternary report adds

What a Precision Deep Dive provides for FML.

A Ternary Health Precision Deep Dive for FML maps the full lipoma burden, identifies coexisting adipose disorders, evaluates family pedigree, audits surgical and procedural options including the comparative evidence for excision vs. lipectomy techniques, and screens for systemic comorbidities that change management.

See the published sample reports · read the Ternary Method

Frequently coexisting conditions

What we look for alongside FML.

Patients with Familial Multiple Lipomatosis frequently present with one or more of the following. Ternary reports evaluate the full picture rather than the condition in isolation.

Common questions — Familial Multiple Lipomatosis

What prospective Familial Multiple Lipomatosis clients ask most.

Is FML the same as Madelung's Disease or Dercum's Disease?
No, but they overlap. FML produces multiple discrete encapsulated lipomas, often across the trunk and extremities, with strong family history. Madelung's produces symmetric, non-encapsulated lipomatous infiltration in characteristic head-and-neck-shoulder patterns. Dercum's lipomas are painful and accompanied by fatigue and cognitive symptoms. Many patients have features of more than one disorder, which is why the differential evaluation matters.
Should I have my lipomas removed?
Depends on size, location, symptom status, growth rate, and your priorities. The Ternary report categorizes lesions into observation, monitor-with-criteria, and remove categories, with surgical technique recommendations per lesion. Removing every lipoma is rarely the right answer; targeted intervention is.
Do I need a confirmed diagnosis before applying?
Multiple lipomas with family history is enough. Pathology confirmation on any single lesion confirms lipoma; the FML diagnosis is clinical and based on count, distribution, and pedigree. We can frame the diagnostic picture if it hasn't been formalized.
Will my children inherit this?
In autosomal dominant FML kindreds, each child has approximately a 50% risk. Penetrance and expression vary. The pedigree work and counseling implications are part of the report when family planning is in scope.
Can you help me choose between excision and liposuction?
Yes. The choice is lesion-specific, not patient-specific. Some lipomas — large, deep, infiltrating — are better treated with open excision. Others — smaller, in cosmetically sensitive areas, in distribution patterns — respond well to liposuction-based debulking. We build the per-lesion recommendation into the surgical decision framework.
Working through this on your own?

Three ways to engage Ternary on FML.

From a free starting point to a full personalized action plan — three tiers, one methodology, all tailored to FML.

Start exploring

Free Brief

$0

A 3–5 page personalized starting point on your condition. Most relevant labs, specialist categories, first decisions worth pursuing. No charge.

Generated instantly, no charge.

Get a free Brief
Get organized

Launchpad

$400

A research-based preparedness guide. Current literature, realistic prognosis, test and treatment categories worth exploring, and a checklist of what you might consider to better manage and understand your condition.

Delivered in 3–5 business days

Start a Launchpad
Get answers

Precision Deep Dive

$6,500

A vigorously researched and highly personalized action plan: the specialists and centers of excellence worth considering, evidence-graded options, and a prioritized set of questions to raise — all curated for your specific condition and lifestyle, for you and your physicians to weigh together. The plan includes 30 days of follow-up support and tailored insights into how best to navigate your situation now and in the future.

September 2026 cohort

Apply for a Deep Dive
What a Ternary report looks like

See exactly what you receive.

A composite sample illustrating the structure and depth of every Ternary Health Precision Deep Dive. Same universal 17-section format used for FML — drawn from four research-validated patient profiles across four conditions.

Every Ternary engagement produces a report with the same architecture: client profile, applied methodology, signal analysis, lab and genetic findings, imaging synthesis, disease model, intervention prioritization, specialist pathway, staged medical therapy, 90-day roadmap, and monitoring cadence. The composite shows you exactly how that architecture renders.

Ready for clarity on your FML?

Applications for the September 2026 cohort are open now and reviewed in the order received. Not ready? A free Ternary Brief on FML is generated instantly, no charge.